Back to Authors

Qiu, Quan

0000-0002-2518-3566

Mayo Clinic

Northwestern University

Citations 1

DBC1 Is a Suppressor of B Cell Activation by Negatively Regulating Alternative NF-κB Transcriptional Activity
Kong, Sinyi, Thiruppathi, Muthusamy , Lin, Zhenghong , Dong, Hongxin , Chini, Eduardo N. , Fang, Deyu , Qiu, Quan , Prabhakar, Bellur S.

The Journal of Immunology | November 1, 2014 | Volume: 193 | Issue: 11 | Pages: 5515-5524

10.4049/jimmunol.1401798 Get It

Abstract CD40 and BAFFR signaling play important roles in B cell proliferation and Ig production. In this study, we found that B cells from mice with deletion of Dbc1 gene (Dbc1−/−) show elevated proliferation, and IgG1 and IgA production upon in vitro CD40 and BAFF, but not BCR and LPS stimulation, indicating that DBC1 inhibits CD40/BAFF-mediated B cell activation in a cell-intrinsic manner. Microarray analysis and chromatin immunoprecipitation experiments reveal that DBC1 inhibits B cell function by selectively suppressing the transcriptional activity of alternative NF-κB members RelB and p52 upon CD40 stimulation. As a result, when immunized with nitrophenylated-keyhole limpet hemocyanin, Dbc1−/− mice produce significantly increased levels of germinal center B cells, plasma cells, and Ag-specific Ig. Finally, loss of DBC1 in mice leads to higher susceptibility to experimental autoimmune myasthenia gravis. Our study identifies DBC1 as a novel regulator of B cell activation by suppressing the alternative NF-κB pathway.